This year’s 40th National Oncology Conference from the Association of Community Cancer Centers (ACCC) will take place in Austin, Texas, from October 4-6, with content designed to reflect the theme of “Reimagining Innovation.”
The Association of Community Cancer Centers (ACCC) 40th National Oncology Conference will take place in person in Austin, Texas, October 4-6, with content designed to reflect the theme of “Reimagining Innovation.” Particular areas of focus include workforce burnout, value-based care, improving the patient experience, and championing women leaders to succeed in oncology. President for the 2023-2024 term, Olalekan Ajayi, PharmD, MBA, chief operating officer of Highlands Oncology Group, PA, took the helm from David Penberthy, MD, 2022-2023 ACCC president, who is now with PennState Health, at the 49th Annual Meeting and Cancer Center Business Summit, held March 8-10, in Washington, DC.
Preconference activities will take place on Wednesday, October 4, encompassing 3 sessions: “ACCC Financial Advocacy Network” will cover how cancer programs and practices can best deliver comprehensive financial advocacy services, using census survey data to pinpoint potential areas of improvement; “Examining the Current Environment for Value-Based Care” will address benefits and challenges from participation in the Enhancing Oncology Model, Medicare Advantage value-based care, and care delivery and advocacy; and “Clinical Updates From Chicago – A Focus on What Community Centers Need to Know to Move Their Solid Tumors' Practices Forward,” will be a CME session.
A new feature this year will be the poster presentations, which will take place on the evening of October 4 and cover topics ranging from food insecurity to health disparities to improving workplace wellness and morale to financial navigation. So far, 25 posters are being presented, but there is potential for more to be added in the days leading up to the conference kick-off.
“Women Leaders in Oncology: A Panel Discussion” will be a highlight on the morning of Friday, October 6. Moderated by Debra Patt, MD, PhD, MBA, executive vice president of policy and strategic initiatives and director of public policy at Texas Oncology, the 7 panelists are set to address the underrepresentation of women physicians and nonphysicians in the health care space. Topics they will address include their journeys to becoming leaders at their practices/cancer centers and how women of color face a different, sometimes more difficult, leadership path; how they overcame their biggest barrier to professional growth and career advancement; and helping other women succeed as leaders.
In addition, over the 3 days of the conference, there will be 30 sessions, 6 of which will be presentations on Thursday, October 5, from the winners of this year’s ACCC Innovator Awards program now in its 13th year: Duke Cancer Institute, Mount Sinai Health System, Oncology Hematology Care Inc, Orlando Health Cancer Institute, Rochester Regional Health-Lipson Cancer Institute, and St. Elizabeth Cancer Center.
There will also be plenty of opportunity for networking, with the exhibit hall open Wednesday evening, all day Thursday, and through early afternoon on Friday. Sprinkled in between sessions will be networking breaks and opportunities at breakfast and lunch to meet with exhibitors.
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
Legal Navigation Services Key to Addressing Disparities in Cancer Care
July 31st 2025A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
Read More